Dr. Reddy’s To Acquire Select Brands From Glenmark In Russia, Ukraine
Hyderabad, Nov.29 (Hydnow): Dr. Reddy’s Laboratories on Saturday announced that it has entered into a definitive agreement with Glenmark Pharmaceuticals to acquire, subject to completion of certain precedent actions and…
‘Dr. Reddy’s Launches Succinylcholine Chloride Injection In US
Hyderabad, Nov.13 (Hydnow): Dr. Reddy’s Laboratories yesterday announced the launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL), in the US Market. Dr. Reddy’s Laboratories along with its…
Dr. Reddy’s Laboratories Launches Methylphenidate Hydrochloride Extended-Release Tablets
Hyderabad, Sept.3 (Hydnow): Dr. Reddy’s Laboratories announced the launch Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a therapeutic equivalent generic version of Concerta…
Dr. Reddy’s Laboratories Launches Penicillamine Capsules USP, 250 mg
Hyderabad, Aug.27 (Hydnow): Dr. Reddy’s Laboratories launched of Penicillamine Capsules USP, 250 mg, a therapeutic equivalent generic version of Cuprimine (penicillamine) Capsules, 250 mg, approved by the U.S. Food and…
Dr. Reddy’s Laboratories Launches Ciprofloxacin 0.3% Medicine
Hyderabad, Aug.11 (Hydnow): Dr. Reddy’s Laboratories today announced the launch of Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, a therapeutic equivalent generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone…
Reddy’s Laboratories Announces Launch Of Abiraterone Acetate Tablets
Hyderabad, June 19 (Hydnow): Dr. Reddy’s Laboratories announced launch of Abiraterone Acetate Tablets USP, 250 mg, a therapeutic equivalent generic version of Zytiga (abiraterone acetate) approved by the U.S. Food…
Dr. Reddy’s Labs In Licensing Pact With Gilead Sciences For Remdesivir
Hyderabad, June 13 (Hydnow): Dr. Reddy’s Laboratories said it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead) that will grant Dr. Reddy’s the right to register,…
Dr. Reddy’s Announces Launch Of Colchicine Tablets USP In US
Hyderabad, June 12 (Hydnow): Dr. Reddy’s Laboratories said launch of Colchicine Tablets USP, a therapeutic equivalent generic version of Colcrys (colchicine) Tablets, 0.6 mg, approved by the US. Food and…